Junyi Li

Junyi Li possesses extensive experience in clinical pharmacology, having worked at Genentech as a Principal Scientist and Scientist from October 2019 to October 2022, focusing on clinical study design for bispecific products in the immunology and oncology areas. Prior to this, Junyi Li served as an ORISE Fellow at the FDA from May 2017 to September 2019, contributing to the development of PD biomarkers for Biologics License Applications and conducting meta-analyses on pharmacokinetics. Junyi Li also has a background in academic instruction as a Teaching Associate at the University of Pittsburgh from September 2014 to July 2018. Educational qualifications include a Ph.D. in Pharmaceutical Sciences with a Pharmacology track and a Master's degree in Biochemical Pharmacology, both from the University of Pittsburgh.